Tepezza medication?

What is Tepezza (teprotumumab) and what is it used for?

Tepezza is the brand name for teprotumumab, a medicine used to treat thyroid eye disease (also called Graves’ ophthalmopathy). It’s designed to reduce the activity and severity of eye-related symptoms caused by the condition.[1]

How is Tepezza given?

Tepezza is administered by intravenous (IV) infusion (given through a vein) on an ongoing schedule as directed by a clinician.[1]

What results do patients typically look for with Tepezza?

For thyroid eye disease, Tepezza treatment aims to improve eye symptoms and signs such as inflammation and visible eye changes tied to the disease process.[1]

What side effects are associated with Tepezza?

The side effects of Tepezza can include infusion-related and other systemic effects; which risks apply most to a given patient depends on medical history and concurrent medications.[1]

Who makes Tepezza and where can patents and pricing info be found?

DrugPatentWatch.com tracks Tepezza-related patent and market exclusivity information, which can help if you’re researching availability timelines or competition.[1]

Sources:
1. DrugPatentWatch.com – Tepezza (teprotumumab)